T. Rowe Price Associates
ALHC icon

T. Rowe Price Associates’s Alignment Healthcare ALHC Stock Holding History

T. Rowe Price Associates’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
4,939,145
-802,161
-14% -$15.4M 0.01% 652
2026
Q1 		$101M Buy
5,741,306
+275,189
+5% +$5.53M 0.01% 608
2025
Q4 		$108M Sell
5,466,117
-107,082
-2% -$1.92M 0.01% 613
2025
Q3 		$97.3M Buy
5,573,199
+3,379,326
+154% +$50.1M 0.01% 626
2025
Q2 		$30.7M Sell
2,193,873
-5,548
-0.3% -$89.3K ﹤0.01% 859
2025
Q1 		$41M Buy
2,199,421
+193,644
+10% +$2.89M 0.01% 779
2024
Q4 		$22.6M Buy
2,005,777
+694,761
+53% +$8.12M ﹤0.01% 970
2024
Q3 		$15.5M Buy
1,311,016
+1,258,648
+2,403% +$11.9M ﹤0.01% 1048
2024
Q2 		$410K Buy
52,368
+7,519
+17% +$49.1K ﹤0.01% 2272
2024
Q1 		$223K Sell
44,849
-1,024,897
-96% -$6.56M ﹤0.01% 2565
2023
Q4 		$9.21M Sell
1,069,746
-55,795
-5% -$408K ﹤0.01% 1114
2023
Q3 		$7.81M Sell
1,125,541
-181,746
-14% -$1.1M ﹤0.01% 1106
2023
Q2 		$7.52M Sell
1,307,287
-70,170
-5% -$454K ﹤0.01% 1119
2023
Q1 		$8.76M Sell
1,377,457
-386,104
-22% -$3.68M ﹤0.01% 1086
2022
Q4 		$20.7M Sell
1,763,561
-391,084
-18% -$4.76M ﹤0.01% 904
2022
Q3 		$25.5M Sell
2,154,645
-6,651,242
-76% -$97.1M ﹤0.01% 836
2022
Q2 		$100M Buy
8,805,887
+236,652
+3% +$2.5M 0.01% 658
2022
Q1 		$96.2M Buy
8,569,235
+654,309
+8% +$5.89M 0.01% 743
2021
Q4 		$111M Sell
7,914,926
-549,331
-6% -$9.62M 0.01% 729
2021
Q3 		$135M Buy
8,464,257
+587,020
+7% +$11.3M 0.01% 675
2021
Q2 		$177M Buy
7,877,237
+47,690
+0.6% +$1.16M 0.02% 599
2021
Q1 		$165M Buy
+7,829,547
New +$153M 0.02% 610

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates's ALHC Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Alignment Healthcare (ALHC) stake by 14% in Q2 2026, selling an estimated $15.4M and leaving 4,939,145 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #652.

T. Rowe Price Associates first reported a position in ALHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $177M in Q2 2021. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • T. Rowe Price Associates held 4,939,145 shares of Alignment Healthcare worth $118M as of Q2 2026.
  • T. Rowe Price Associates sold 802,161 Alignment Healthcare shares in Q2 2026, an estimated $15.4M.
  • Alignment Healthcare made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #652 holding.
  • T. Rowe Price Associates first reported a position in Alignment Healthcare in Q1 2021 and has held it in 22 quarters since.
  • T. Rowe Price Associates's Alignment Healthcare position peaked at $177M in Q2 2021.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.